SCHEMBL5166417

SCHEMBL5166417

ClCCCSCc1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
CYP1A2 P05177 2/20 0.51
TSHR P16473 1/20 0.51
CHRM2 P08172 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
MAPK1 P28482 1/20 0.45
LMNA P02545 1/20 0.45
HRH1 P35367 2/20 0.44
KDM4E B2RXH2 2/20 0.42
MAPT P10636 3/20 0.41
LIN28A Q9H9Z2 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYP2E1 P05181 1/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10737445 0.95 ALDH1A1 (0.50) ALDH1A1CYP1A2TSHRCHRM2SMN1; SMN2
SCHEMBL22922233 0.87 ALDH1A1 (0.53) ALDH1A1CYP1A2TSHRCHRM2SMN1; SMN2
SCHEMBL31058796 0.86 ALDH1A1 (0.59) ALDH1A1CYP1A2TSHRSMN1; SMN2NPC1
SCHEMBL9355545 0.84 ALDH1A1 (0.47) ALDH1A1CYP1A2TSHRCHRM2SMN1; SMN2
SCHEMBL30732408 0.84 ALDH1A1 (0.58) ALDH1A1CYP1A2TSHRSMN1; SMN2NPC1
SCHEMBL12055882 0.84 ALDH1A1 (0.58) ALDH1A1CYP1A2TSHRSMN1; SMN2NPC1
SCHEMBL8413014 0.84 ALDH1A1 (0.50) ALDH1A1CYP1A2TSHRCHRM2SMN1; SMN2
SCHEMBL422540 0.84 ALDH1A1 (0.54) ALDH1A1CYP1A2TSHRCHRM2SMN1; SMN2
SCHEMBL5169553 0.84 HRH1 (0.56) ALDH1A1CYP1A2TSHRCHRM2SMN1; SMN2
SCHEMBL9595524 0.82 ALDH1A1 (0.53) ALDH1A1CYP1A2TSHRCHRM2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187846-B1 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2007-04-18 EP disclosed
US-6790842-B1 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-09-14 US disclosed
EP-1187846-A2 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS Schering Aktiengesellschaft (DE) 2002-03-20 EP disclosed
WO-2001000652-A2 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2001-01-04 WO disclosed
US-4272534-A 2-(Pyrid-2-yl)tetrahydrothiophene derivatives RHONE-POULENC INDUSTRIES (FR) 1981-06-09 US disclosed